MedPath

BOSTON IVF

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
https://www.bostonivf.com/

FemBloc Non-Surgical Birth Control Shows 100% Effectiveness in Clinical Trials with Five-Year Safety Data

• Clinical trials of FemBloc, a novel non-surgical permanent birth control method, demonstrated 0% pregnancy rate among eligible participants, significantly outperforming the 6% benchmark for surgical sterilization. • The innovative procedure, utilizing synthetic tissue adhesive for fallopian tube occlusion, reported no serious adverse events across 229 participants during five years of follow-up. • Patient and practitioner satisfaction rates were notably high, positioning FemBloc as a promising alternative to traditional surgical sterilization methods.
© Copyright 2025. All Rights Reserved by MedPath